| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9721 |
| Human Intestinal Absorption | HIA+ | 0.9808 |
| Caco-2 Permeability | Caco2+ | 0.6571 |
| P-glycoprotein Substrate | Non-substrate | 0.7017 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7256 |
| Non-inhibitor | 0.9207 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9094 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8365 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8224 |
| CYP450 2D6 Substrate | Non-substrate | 0.9255 |
| CYP450 3A4 Substrate | Non-substrate | 0.6477 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5961 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6977 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9464 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8198 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9298 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7130 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9860 |
| Non-inhibitor | 0.9470 |
| AMES Toxicity | Non AMES toxic | 0.8602 |
| Carcinogens | Non-carcinogens | 0.5583 |
| Fish Toxicity | High FHMT | 0.9785 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9403 |
| Honey Bee Toxicity | High HBT | 0.6667 |
| Biodegradation | Ready biodegradable | 0.5484 |
| Acute Oral Toxicity | III | 0.5481 |
| Carcinogenicity (Three-class) | Non-required | 0.6598 |